Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, 430000, China.
Hubei Clinical Center and Key Lab of Intestinal and Colorectal Diseases, Wuhan, 430000, China.
BMC Gastroenterol. 2023 Jan 7;23(1):4. doi: 10.1186/s12876-022-02621-2.
Immune cells and stromal cells in the tumor microenvironment play a vital role in the progression of colorectal cancer (CRC). The study aimed to screen valuable prognostic biomarkers in CRC based on stromal and immune scores.
The ESTIMATE algorithm was used to calculate the immune and stromal scores of CRC samples in TCGA. Then samples were divided into high and low score groups based on the median value of the scores. Differentially expressed genes (DEGs) associated with immune and stromal scores were screened. WGCNA and univariate COX regression analysis were performed to further identify key prognostic genes. Analysis of scRNA-seq for CRC was used for verifying the main source of the key genes. The prognostic value of they was validated based on The Gene Expression Profiling Interactive Analysis and GSE17536 dataset. TIMER and CIBERSORT algorithms were applied to analyze the correlations among key genes and tumor-infiltrating immune cells. Several pairs of colon cancer tissue were used to be proven.
1314 upregulated and 4 downregulated genes were identified, which were significantly enriched in immune-related biological processes and pathways. Among these DEGs, SPOCK1 and POSTN were identified as key prognostic genes and mainly expressed in cancer-associated fibroblasts for CRC. High expression of SPCOK1 and POSTN was associated with advanced clinical stage, T stage, N stage, and poor prognosis of CRC. The results from CIBERSORT and TIMER revealed that SPOCK1 and POSTN were associated with tumor-infiltrating immune cells, especially macrophages and neutrophils. Meanwhile, in several pairs of human colorectal tissue samples, SPOK1 and POSTN were found to be significantly overexpressed in colorectal tissue compared with para-cancer tissue, and macrophage surface markers CD68 (co-expressed by M1 and M2 macrophages) and CD206 (M2-specific macrophage expression) were also overexpressed in cancer tissue. Besides, SPOCK1 and POSTN expression were positively correlated with the expression of immune checkpoints.
Collectively, our results indicate that SPOCK1 and POSTN associated with CAF may be novel prognostic biomarkers in CRC and correlate with immune infiltrates.
肿瘤微环境中的免疫细胞和基质细胞在结直肠癌(CRC)的进展中起着至关重要的作用。本研究旨在基于基质和免疫评分筛选 CRC 中有价值的预后生物标志物。
使用 ESTIMATE 算法计算 TCGA 中 CRC 样本的免疫和基质评分。然后根据评分的中位数将样本分为高分和低分组。筛选与免疫和基质评分相关的差异表达基因(DEGs)。进行 WGCNA 和单因素 COX 回归分析,以进一步鉴定关键预后基因。使用 CRC 的 scRNA-seq 分析验证关键基因的主要来源。基于 The Gene Expression Profiling Interactive Analysis 和 GSE17536 数据集验证它们的预后价值。应用 TIMER 和 CIBERSORT 算法分析关键基因与肿瘤浸润免疫细胞之间的相关性。使用几对结肠癌组织进行验证。
鉴定出 1314 个上调和 4 个下调基因,这些基因显著富集在与免疫相关的生物学过程和途径中。在这些 DEGs 中,SPOCK1 和 POSTN 被鉴定为关键预后基因,并且主要在 CRC 中的癌相关成纤维细胞中表达。SPCOK1 和 POSTN 的高表达与 CRC 的晚期临床分期、T 分期、N 分期和不良预后相关。CIBERSORT 和 TIMER 的结果表明,SPOCK1 和 POSTN 与肿瘤浸润免疫细胞有关,尤其是巨噬细胞和中性粒细胞。同时,在几对人结直肠组织样本中,与癌旁组织相比,SPOK1 和 POSTN 在结直肠组织中明显过表达,并且巨噬细胞表面标志物 CD68(M1 和 M2 巨噬细胞共表达)和 CD206(M2 特异性巨噬细胞表达)也在癌组织中过表达。此外,SPOCK1 和 POSTN 的表达与免疫检查点的表达呈正相关。
综上所述,我们的研究结果表明,与 CAF 相关的 SPOCK1 和 POSTN 可能是 CRC 中的新型预后生物标志物,并与免疫浸润有关。